US FDA accepted NDA filing for ensifentrine for maintenance treatment of COPD PDUFA Target Action Date of June 26, 2024 Commercial launch preparations supported by strong balance sheet Conference.
Verona Pharma plc announced effective September 1, 2023, Ms. Christina Ackermann will join the board as a Non-Executive Director. Ms. Ackermann brings over 25 years of legal and management experience.
LONDON and RALEIGH, N.C., Aug. 31, 2023 Verona Pharma plc , announces effective September 1, 2023, Ms. Christina Ackermann will join the board as a Non-Executive Director. Ms. Ackermann brings.
Christina Ackermann Joins Verona Pharma as Non-Executive Director itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
LONDON and RALEIGH, N.C., Aug. 31, 2023 (GLOBE NEWSWIRE) Verona Pharma plc (NASDAQ:VRNA) ("Verona Pharma"), announces effective September 1, 2023, Ms. Christina Ackermann will join the board as a Non-Executive